Data as of Aug 01
| -0.23 / -1.72%|
The 5 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 18.00, with a high estimate of 19.00 and a low estimate of 16.00. The median estimate represents a +37.20% increase from the last price of 13.12.
The current consensus among 7 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.